Jundishapur Journal of Microbiology

Published by: Kowsar

Genetic Determinants of Resistance to Fusidic Acid Among Staphylococcus aureus Isolates in Jordan

Rasha Aldasouqi 1 , Luay F. Abu-Qatouseh 2 , Eman F. Badran 3 , Sameer A. Alhaj Mahmoud 4 and Rula Madhat Darwish 1 , *
Authors Information
1 Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman, Jordan
2 Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy, University of Petra, Amman, Jordan
3 Department of Paediatrics, Division Neonatology, School of Medicine, The University of Jordan, Amman, Jordan
4 Department of Basic Medical Sciences, Faculty of Medicine, The Hashemite University, Zarka, Jordan
Article information
  • Jundishapur Journal of Microbiology: March 31, 2019, 12 (3); e86120
  • Published Online: March 29, 2019
  • Article Type: Research Article
  • Received: November 6, 2018
  • Revised: March 6, 2019
  • Accepted: March 14, 2019
  • DOI: 10.5812/jjm.86120

To Cite: Aldasouqi R, Abu-Qatouseh L F, Badran E F, Alhaj Mahmoud S A, Darwish R M. Genetic Determinants of Resistance to Fusidic Acid Among Staphylococcus aureus Isolates in Jordan, Jundishapur J Microbiol. 2019 ; 12(3):e86120. doi: 10.5812/jjm.86120.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Kurlenda J, Grinholc M. Alternative therapies in Staphylococcus aureus diseases. Acta Biochim Pol. 2012;59(2):171-84. [PubMed: 22577619].
  • 2. Darwish RM, Ra'ed J, Zarga MHA, Nazer IK. Antibacterial effect of Jordanian propolis and isolated flavonoids against human pathogenic bacteria. Afr J Biotechnol. 2010;9(36):5966-74.
  • 3. Chopra I. Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol. 1976;96(2):229-38. doi: 10.1099/00221287-96-2-229. [PubMed: 993776].
  • 4. O'Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol. 2007;45(5):1505-10. doi: 10.1128/JCM.01984-06. [PubMed: 17344365]. [PubMed Central: PMC1865894].
  • 5. O'Neill AJ, McLaws F, Kahlmeter G, Henriksen AS, Chopra I. Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother. 2007;51(5):1737-40. doi: 10.1128/AAC.01542-06. [PubMed: 17325218]. [PubMed Central: PMC1855526].
  • 6. Lannergard J, Norstrom T, Hughes D. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53(5):2059-65. doi: 10.1128/AAC.00871-08. [PubMed: 19289529]. [PubMed Central: PMC2681530].
  • 7. Laurberg M, Kristensen O, Martemyanov K, Gudkov AT, Nagaev I, Hughes D, et al. Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol. 2000;303(4):593-603. doi: 10.1006/jmbi.2000.4168. [PubMed: 11054294].
  • 8. Huang J, Ye M, Ding H, Guo Q, Ding B, Wang M. Prevalence of fusB in Staphylococcus aureus clinical isolates. J Med Microbiol. 2013;62(Pt 8):1199-203. doi: 10.1099/jmm.0.058305-0. [PubMed: 23639984].
  • 9. Norstrom T, Lannergard J, Hughes D. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51(12):4438-46. doi: 10.1128/AAC.00328-07. [PubMed: 17923494]. [PubMed Central: PMC2168011].
  • 10. Abu-Qatouseh LF, Chinni SV, Seggewiss J, Proctor RA, Brosius J, Rozhdestvensky TS, et al. Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype. J Mol Med (Berl). 2010;88(6):565-75. doi: 10.1007/s00109-010-0597-2. [PubMed: 20151104].
  • 11. Lannergard J, Cao S, Norstrom T, Delgado A, Gustafson JE, Hughes D. Genetic complexity of fusidic acid-resistant small colony variants (SCV) in Staphylococcus aureus. PLoS One. 2011;6(11). e28366. doi: 10.1371/journal.pone.0028366. [PubMed: 22140579]. [PubMed Central: PMC3226684].
  • 12. Moellering RC Jr, Corey GR, Grayson ML. Introduction: Fusidic acid enters the United States. Clin Infect Dis. 2011;52 Suppl 7:S467-8. doi: 10.1093/cid/cir171. [PubMed: 21546622].
  • 13. O'Neill AJ, Chopra I. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus. Mol Microbiol. 2006;59(2):664-76. doi: 10.1111/j.1365-2958.2005.04971.x. [PubMed: 16390458].
  • 14. McLaws F, Chopra I, O'Neill AJ. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. J Antimicrob Chemother. 2008;61(5):1040-3. doi: 10.1093/jac/dkn071. [PubMed: 18299637].
  • 15. Aqel AA, Alzoubi HM, Vickers A, Pichon B, Kearns AM. Molecular epidemiology of nasal isolates of methicillin-resistant Staphylococcus aureus from Jordan. J Infect Public Health. 2015;8(1):90-7. doi: 10.1016/j.jiph.2014.05.007. [PubMed: 25002017].
  • 16. Mattar S, Al-Laham N, Masalha I, Abu-Qatouseh LF. Characterization of capsule expression of both MSSA/MRSA strains isolated from various body sites of colonization and infections in Amman and Gaza. Int Arabic J Antimicrob Agent. 2014;4(2). doi: 10.3823/750.
  • 17. Jones RN, Castanheira M, Rhomberg PR, Woosley LN, Pfaller MA. Performance of fusidic acid (CEM-102) susceptibility testing reagents: Broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus. J Clin Microbiol. 2010;48(3):972-6. doi: 10.1128/JCM.01829-09. [PubMed: 20053856]. [PubMed Central: PMC2832462].
  • 18. European Committee on Antimicrobial Susceptibility Testing. EUCAST Breakpoint tables for interpretation of MICs and zone diameters. Version 1.1. 2010.
  • 19. Elhamzaoui S, Benouda A, Allali F, Abouqual R, Elouennass M. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco]. Med Mal Infect. 2009;39(12):891-5. French. doi: 10.1016/j.medmal.2009.01.004. [PubMed: 19269758].
  • 20. Castanheira M, Watters AA, Mendes RE, Farrell DJ, Jones RN. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008). J Antimicrob Chemother. 2010;65(7):1353-8. doi: 10.1093/jac/dkq094. [PubMed: 20430787].
  • 21. Castanheira M, Watters AA, Bell JM, Turnidge JD, Jones RN. Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008. Antimicrob Agents Chemother. 2010;54(9):3614-7. doi: 10.1128/AAC.01390-09. [PubMed: 20566766]. [PubMed Central: PMC2934946].
  • 22. Hung WC, Chen HJ, Lin YT, Tsai JC, Chen CW, Lu HH, et al. Skin commensal Staphylococci May Act as reservoir for fusidic acid resistance genes. PLoS One. 2015;10(11). e0143106. doi: 10.1371/journal.pone.0143106. [PubMed: 26581090]. [PubMed Central: PMC4651549].
  • 23. Rijnders MI, Wolffs PF, Hopstaken RM, den Heyer M, Bruggeman CA, Stobberingh EE. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands. J Antimicrob Chemother. 2012;67(5):1176-80. doi: 10.1093/jac/dkr590. [PubMed: 22290345].
  • 24. Yu F, Liu Y, Lu C, Lv J, Qi X, Ding Y, et al. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates. BMC Microbiol. 2015;15:210. doi: 10.1186/s12866-015-0552-z. [PubMed: 26463589]. [PubMed Central: PMC4604626].
  • 25. Elazhari M, Abu-Quatouseh LF, Elhabchi D, Zerouali K, Dersi N, Saile R, et al. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco). Int J Med Microbiol. 2012;302(2):96-100. doi: 10.1016/j.ijmm.2011.10.002. [PubMed: 22197537].
  • 26. Chen HJ, Hung WC, Tseng SP, Tsai JC, Hsueh PR, Teng LJ. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother. 2010;54(12):4985-91. doi: 10.1128/AAC.00523-10. [PubMed: 20855746]. [PubMed Central: PMC2981276].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments